TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
PHASE1
The purpose of the study is to evaluate the safety, tolerability, and effic...
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
PHASE4
The purpose of this study is to determine how teriparatide or denosumab aff...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.